Inhibitory effect of PPARγ agonist on the proliferation of human pterygium fibroblasts

The effects of DK2,a peroxisome proliferator-activated receptor γ agonist,on cultured human pterygium fibroblasts (HPFs) in virto were studied.The HPFs were incubated with 0-200 μmol/L DK2 for 12-72 h.The MTT method was used to assay the bio-activity of DK2 at different doses and time.The cytotoxic effect of DK2 was measured by LDH release assay.The cell cycle distribution and apoptosis were flow cytometrically detected.The expression of proliferating cell nuclear antigen (PCNA) in each group was detected by real-time PCR (RT-PCR) and Western blotting.The results showed that administration of 1-75 μmol/L DK2 for 12-72 h could significantly inhibit HPF proliferation in a dose-and time-dependent manner.DK2-treated cells did not release significant amount of LDH as compared with rosiglitazone-treated cells.After treatment with DK2 at concentrations of 15,25 μmol/L for 24 h,the number of HPFs in G 0 /G 1 phase was significantly increased while that in S phase was significantly decreased (P<0.05),leading to arrest at G 0 /G 1 phase.The apoptosis rates of HPF cells in drug-treated groups were significantly higher than the rate of control group (P<0.05).At the dosage range between 15-25 μmol/L,DK2 could inhibit the expression of PCNA mRNA and protein in HPFs in a dose-dependent fashion (P<0.05).It was concluded that PPARγ agonist can significantly inhibit HPF proliferation,resulting in the arrest at G 0 /G 1 phase,induce the apoptosis of HPFs,and suppress the synthesis of PCNA,in dose-and time-dependent manners.     

姜黄素对翼状胬肉成纤维细胞抑制作用的研究

目的研究姜黄素对体外培养人翼状胬肉成纤维细胞（human pterygium fibroblasts HPF）增殖的影响,探索翼状胬肉防治新方法。方法用0~80μg/mL姜黄素作用体外培养的人翼状胬肉成纤维细胞,观察24~96h后不同浓度姜黄素对人翼状胬肉成纤维细胞的影响。CCK-8法检测细胞生长活性,流式细胞仪检测细胞周期时相变化。结果在0~80μg/mL浓度作用24~96h范围内,姜黄素可以抑制HPF细胞的增长,且呈剂量和时间依赖性。0、10、20、40、80μg/mL姜黄素作用24h后,姜黄素作用组均出现G0-G1期细胞百分比上升,S期细胞百分比下降,且姜黄素对成纤维细胞的抑制作用呈剂量依赖性。结论姜黄素可抑制体外培养人翼状胬肉成纤维细胞增殖。     

HDAC1 expression and effect of curcumin on proliferation of Raji cells

Summary Histone deacetylase (HDAC₁) has a high expression in many cancer cells and curcumin can inhibit the growth of cancer cells. This paper was designed to investigate the expression of HDAC₁ of Raji cells and the effect of curcumin on their proliferation and apoptosis. Raji cells were treated with 3. 125–50 μmol/L curcumin for 8–48 h and the growth inhibition rates of Raji cells were measured by MTT. The expression of HDAC₁ on Raji cells were examined by mRNA, Western blot at 24 h various concertrations (1.6–50 μmol/L). Curcumin could selectively inhibit the proliferation of Raji cells in a dose and time dependent manner, with the inhibition rate being 52.47%–82.18% (P<0.01). The up-regulation of HDAC₁ expression was observed within 24 h after the treatment with curcumin as shown by RT-PCR and Western blot. With the increase of concentration, the expression was down-regulated in a dose dependent manner. It is concluded that the expression of HDAC₁ plays an important role in the proliferation and apoptosis of Raji cells and curcumin can inhibit the growth of Raji cells at various concentrations and promote the apoptosis of Raji cells. WU Qing, female, born in 1970, M. D., Ph. D. This project was supported by a grant from the National Natural Sciences Foundation of China (No. 30271672).     

Anticancer Effect of Curcumin on Human B Cell non-Hodgkin＇s Lymphoma

Curcumin(diferuloylmethane)isayellowpig mentfromtherhizomesofturmeric(Curcumalon gaL.)andisamajorcomponentofvariousrecipesforcurry.Curcuminhasbeenreportedtohaveanumberofpharmacologicaleffectsincludinganti inflammatory,anti oxidant,antiviral,antibacterialandantitumoreffects,whichisattractingmoreandmoreattentionofinvestigators.Curcuminhasin hibitoryeffectsonmanytumorssuchasfoestom achcancer,esophagealcancer,coloncancer,livercancer,mammarytumor,bladdercancer,skincanceraswellasDMBA inducedleukem…     

Resveratrol Inhibits the Secretion of Vascular Endothelial Growth Factor and Subsequent Proliferation in Human Leukemia U937 Cells

This study examined the effect of resveratrol on the secretion of vascular endothelial growth factor(VEGF) and subsequent proliferation of human leukemia U937 cells,and explored the mechanisms involved.Human leukemia U937 cells were treated with resveratrol of different concentrations(12.5-200 μmol/L) for different time lengths(12-48 h).The proliferation of the U937 leukemic cells was determined by MTT assay.Apoptosis was observed by Annexin-Ⅴ-FIFC/PI double staining and flow cytometry(FCM).Cells cycle was analyzed by PI staining and FCM.The content of VEGF was determined by ELISA.Human umbibical vein endothelial cells were examined for vasoformation in vitro after exposures to resveratrol of various concetrations.The results showed that resveratrol inhibited the proliferation of U937 leukemia cells in a dose-and time-dependent manner.Resveratrol induced apoptosis and S-phase cell cycle arrest in human leukemic U937 cells.Resveratrol inhibited the secretion of VEGF in U937 cells.Resveratrol inhibited the vasoformation of human vein endothelial cells in a dose-dependent manner.It was concluded that resveratrol could down-regulate the secretion of VEGF,induce apoptosis and suppress the proliferation of U937 cells.     

Effects of concurrent use of rh-IFN-γ and curcumin on the antiproliferative capacity of HL-60 cells

Summary To understand the effect of rh-IFN-γ on the ability of curcumin to kill HL-60 cellsin vitro, the myeloid leukemic cell line HL-60 was studied by using cell culture. BrdU incorporation rate was examined by SABC, DNA content was determined by flow cytometry and apoptotic cell percentage was determined by TUNEL method. The results showed that curcumin inhibited proliferation of leukemic cells in a dose-dependent manner. When HL-60 cells were treated with 25 μmol curcumin for 24 h, the proliferative inhibitory rate was 43. 75±2. 00 %. This effect could be enhanced obviously by IFN-γ, the combined proliferative inhibitory rate increased to over 80 %. The 5-BrdU incorportion rate and the distribution of DNA content indicated that curcumin could arrest cells in the G₁,/G₀ and G₂/M phase of cell cycle. At the same time, the sub-G₁ peak (apoptotic peak) appeared. After IFN-γ combined with curcumin DNA synthesis rate decreased further. It showed a significant difference when compared with single drug group (P < 0. 05). Meanwhile, sub-Gi peak also increased. The percentage of TUNEL positive cells was aslo increased. It is concluded that IFN-γ can enhance the antiproliferative ability of curcumin against HL-60 cells.     

姜黄素对人卵巢癌细胞株HO-8910增殖和凋亡的影响

目的:探讨姜黄素对体外培养人卵巢癌HO-8910细胞增殖和凋亡的影响。方法:选用人卵巢癌细胞株HO-8910进行体外培养至对数生长期,以0~80μmol/L姜黄素(5μmol/L,10μmol/L,20μmol/L、40μmol/L、80μmol/L)分别处理HO-8910细胞24、48、72h,四甲基偶氮唑蓝(MTT)实验测定细胞的生长抑制率;流式细胞仪检测不同浓度药物对细胞凋亡率的影响;免疫组化法检测PCNA在细胞中的表达,评价细胞的增殖状态。结果:姜黄素对HO-8910细胞增殖抑制率随药物浓度增加及作用时间延长有升高趋势,呈时间剂量依赖性。姜黄素作用24h随浓度的升高PCNA阳性表达逐渐降低。流式细胞仪分析证实随着浓度的升高细胞凋亡率和膜受损率均提高。结论:姜黄素对人卵巢癌细胞株HO-8910的生长有显著的抑制作用,并能诱导其凋亡。     

Inhibitory effects of Celecoxib and Sc-58125 on proliferation of human carcinoma of larynx Hep-2 in vitro

Summary The inhibitory effects of two kinds of selective cyclooxygenase-2 inhibitors on the proliferation of human carcinoma of larynx Hep-2in vitro and their corresponding mechanisms were investigated. Hep-2 cells were cultured with two kinds of selective cyclooxygenase-2 inhibitors (Sc-58125 and Celecoxib) at various concentration for 24 h. Morphological changes were observed under the phase microscopy and the growth suppression was detected by using MTT colorimetric assay. Apoptotic DNA fragments were observed by agarose gel electrophoresis and the cell cycle and apoptotic rate were detected by flow cytometry (FCM) respectively. Hep-2 cells became rounded and detached from the culture dish after being treated with Celecoxib for 24 h, however, they remained morphologically unchanged with Sc-58125. Sc-58125 could increase G₂ phase cells, whereas, Clecoxib rose G₁ phase cells. Both of the two effects were dose-dependent. Moreover, the Hep-2 cells cultured with 50μmol/L and 100μmol/L Celecoxib showed obvious apoptosis, with the nuclear DNA of cells exhibiting characteristic DNA ladder. So Sc-58125 could inhibit the proliferation of Hep-2 cells by altering the G₂ phase cells. However, Celecoxib had the same effect by changing the G₁ phase cells and inducing apoptosis at higher concentration. DING Juan, female, born in 1977, M. D., Ph. D. This project was supported by the Teaching and Research Award Program for Outstanding Young Teachers in Higher Education Institutions of MOE of China     

Effect of amygdalin on the proliferation of hyperoxia-exposed type II alveolar epithelial cells isolated from premature rat

Summary The pathogenesis of hyperoxia lung injury and the mechanism of amygdalin on type 2 alveolar epithelial cells (AEC2) isolated from premature rat lungsin vitro were investigated. AEC2 were obtained by primary culture from 20-days fetal rat lung and hyperoxia-exposed cell model was established. Cell proliferating viability was examined by MTT assay after treatment of amygdalin at various concentrations. DNA content and the proliferating cell nuclear antigen (PCNA) protein expression of AEC2 were measured by using flow cytometry and immunocytochemistry respectively after 24h of hyperoxia exposure or amygdalin treatment. The results showed that hyperoxia inhibited the proliferation and decreased PCNA protein expression in AEC2 of premature ratin vitro. Amygdalin at the concentration range of 50–200 μmol/L stimulated the proliferation of AEC2 in a dose-dependent manner, however, 400 μmol/L amygdalin inhibited the proliferation of AEC2. Amygdalin at the concentration of 200 μmol/L played its best role in facilitating proliferation of AEC2sin vitro and could partially ameliorated the changes of proliferation in hyperoxia exposed AEC2 of premature rat. It has been suggested that hyperoxia inhibited the proliferation of AEC2s of premature rat, which may contribute to hyperoxia lung injury. Amygdalin may play partial protective role in hyperoxia-induced lung injury. ZHU Huaping, female, born in 1972, M. D., Ph.D.     

Effects of POH in Combination with STI571 on the Proliferation and Apoptosis of K562 Cells

Sofar ,the 2 phenylaminopyrimidineSTI5 71isthemostsuccessfulofthemolecularlydesignedATPcompetitorsfromNovartisPharma (Basel,Switzer land) ,whichspecificallyinhibitsAbltyrosinekinaseatmicromolarconcentrations .InhibitionoftheBcr Ablkinaseactivitybythiscom…     

Experimental Study on the Inhibitory Effects of Verapamil on the Proliferation of Meningiomas Cells

In order to investigate the effects of verapamil on the proliferation of meningiomas cells in vitro and in vivo, the cultured meningiomas cells were cultured with verapamil at different concen-trations for 24 h and the inhibitory effects of verapamil on cell proliferation were observed by MTT method. The meningiomas model was established by implanting the newly removed tumor fragments into the nude mice subcutaneously. The nude mice with tumors were divided into two groups: vera-pamil-treated group and control group. Tumor volumes were measured and after 12 weeks the tumors were taken out and examined histologically. The expression of proliferating cell nuclear antigen (PCNA) in the tumors was detected by using immunohistochemistry. It was found that verapamil could inhibit the growth of cultured meningiomas cells in a concentration-dependant manner. The in-hibitory effect could be observed in the concentration of 1 μmol/L verapamil and the most obvious effects appeared in the concentration of 100 μmol/L. Tumor volume in the verapamiltreated group was obviously smaller than that in the control group (211.40±5.50 vs 163.94±3.62, P<0.01) and the expression of PCNA was also lower (1.52±0.24 vs 2.86±0.53, P<0.05). Tumor inhibition rate was about 22.45%. It was suggested that verapamil could inhibit the proliferation and growth of men-ingiomas cells in vitro and in vivo.     

Growth-inhibitory Effects of Curcumin on Ovary Cancer Cells and Its Mechanisms

Sinceanti carcinogenicagentsalsobringabouttheapoptosisinnormalcellswhiletheyinduceapop tosisinneoplasmcells ,inrecent years ,efforthasbeendirectedatlookingforneweffectiveanti cancerdrugswithlowtoxicity .Curcuministhemajoractivecomponentofcurcuma ,whichisa…     

Preparation of curcumin prodrugs and theirin vitro anti-tumor activities

Summary The curcumin prodrugs, which could be selectively activated in tumor cells, were prepared to establish a basis for the targeted chemotherapy for cancer. On the basis of the molecular structure of curcumin, the N-maleoyl-L-valine-curcumin (NVC), N-maleoyl- glycine-curcumin (NGC) were chemically synthesized and identified by IR and NMR spectroscopy. After treatment with these two prodrugs for 6–24 h, the rates of growth inhibition on human bladder cancer EJ cells and renal tubular epithelial (HKC) cells were detected by MTT colorimetry. Our results showed that after the treatment with 20 μmol/L–40 μmol/L NVC and NGC for 6–24 h, the growth inhibitory effects on EJ cells were 6.71%–65.13% (P<0.05), 10.96%–73.01% (P<0.05), respectively, in both dose- and time-dependent manners. When compared with the curcumin of same concentrations, the growth inhibitory effects of these two prodrugs on HKC cells were significantly decreased (P<0.01). It is concluded that activation of curcumin prodrugs via hydrolysis functions of cellular esterase could inhibit the growth activities of tumor cells, and reduce the side effects on normal diploid cells. This provided a novel strategy for further exploration of tumor-targeted chemotherapeutic drugs. LU Peng, male, born in 1977, M. D., Ph. D. This project was supported by a grant from the National Natural Sciences Foundation of China (No. 30200284).     

Effect of DRB on the Biological Characteristics of Human Laryngeal Carcinoma Hep-2 Cell Line

In order to study the effect of 5, 6-Dichloro-1-β-D-ribofuranosyl-benzimidazole (DRB) on the biological characteristics of human laryngeal carcinoma Hep-2 cell line in vitro, Hep-2 cells cultured in vitro were treated with different concentrations of DRB. Changes in cell proliferation, apoptotic rate and invasiveness were detected by MTT assay, flow cytometry (FCM) and matrigel in vitro invasion assay, respectively. It was found that DRB inhibited the proliferation of Hep-2 cells in a dose- and time-dependent manner. After being treated with 0, 10, 20, 40, 80 μmmol/L DRB for 24 h, the apoptotic rate in Hep-2 cells was (0.68±0.19)%, (1.95±0.12)%, (8.51±0.26)%, (11.26±0.17)% and (14.99±0.32)%, respectively. The matrigel in vitro invasion assay revealed that DRB began to inhibit the invasion of Hep-2 cells at the concentration of 5 μmmol/L, and with the increase of DRB concen-tration, the inhibitory effect was enhanced. It was suggested that DRB could influence the essential biological characteristics of Hep-2 cells, inhibit Hep-2 cells proliferation, reduce invasive ability and induce apoptosis of Hep-2 cells.     

Dracorhodin perchlorate suppresses proliferation and induces apoptosis in human prostate cancer cell line PC-3

The growth inhibition and pro-apoptosis effects of dracorhodin perchlorate on human prostate cancer PC-3 cell line were examined. After administration of 10-80 μmol/L dracorhodin perchlorate for 12-48 h, cell viability of PC-3 cells was measured by MTT colorimetry. Cell proliferation ability was detected by colony formation assay. Cellular apoptosis was inspected by acridine orange-ethidium bromide fluorescent staining, Hoechst 33258 fluorescent staining, and flow cytometry (FCM) with annexin Ⅴ-FITC/propidium iodide dual staining. The results showed that dracorhodin perchlorate inhibited the growth of PC-3 in a dose- and time-dependent manner. IC50 of dracorhodin perchlorate on PC-3 cells at 24 h was 40.18 μmol/L. Cell clone formation rate was decreased by 86% after treatment with 20 μmol/L of dracorhodin perchlorate. Some cells presented the characteristic apoptotic changes. The cellular apoptotic rates induced by 10-40 μmol/L dracorhodin perchlorate for 24 h were 8.43% to 47.71% respectively. It was concluded that dracorhodin perchlorate significantly inhibited the growth of PC-3 cells by suppressing proliferation and inducing apoptosis of the cells.     

Effects of Trichostatin A on HDAC8 Expression, Proliferation and Cell Cycle of Molt-4 Cells

The effects of Trichostatin A (TSA) on histone deacetylase 8 (HDAC8) expression, proliferation and cell cycle arrest in T-lymphoblastic leukemia cell line Molt-4 cells in vitro were investigated. The effect of TSA on the growth of Molt-4 cells was studied by MTT assay. Flow cytometry was used to examine the cell cycle. The expression of HDAC8 was detected by using immunocyto-chemistry and Western blot. The results showed that proliferation of Molt-4 cells was inhibited in TSA-treated group in a time- and dose-dependent manner. The IC50 of TSA exposures for 24 h and 36 h were 254.3236 and 199.257μg/L respectively. The cell cycle analysis revealed that Molt-4 was mostly in G0/G1 phase, and after treatment with TSA from 50 to 400μg/L for 24 h, the percents of G0/G1 cells were decreased and cells were arrested in G2/M phase. Treatment of TSA for 24 h could significantly inhibit the expression of HDAC8 protein in Molt-4 cells (P<0.01). It was concluded that TSA could decrease the expression of HD AC8 in Molt-4 cells, which contributed to the inhibition of proliferation and induction of cell cycle arrest in Molt-4 cells.     

The influence of curcumin on the cell cycle of Hl-60 cells- and contrast study

Over the past years, the new research findingshave shown that cancer development depends onwhether normal cell cycle is permanently disturbed.Abnormal cell cycle may contribute to uncontrolledcell growth, ace urn "lating. mutat ion and fin al c arc ino-genesis instead of progammed cell death (PCD)[1]. Itis now widely accepted that curcumin possesses definite anticancer effects by inhibition of the cancer cellproliferation. In order 'to understand further themechanism of curcumin against acute…     

Effects of betulinic acid on proliferation and apoptosis in Jurkat cells and its in vitro mechanism

Summary  The anti-cancer effects of betulinic acid (BA) on Jurkat cells and its in vitro mechanism were examined by using MTT assay. Apoptosis was detected by using Hoechst33258 staining and annexin-V/PI double-labeled cytometry. The effects of betulinic acid on the cell cycle of Jurkat cells were studied by propidium iodide method. RT-PCR and Western blotting were used to analyze the changes of cyclin D3, bcl-xl mRNA and protein levels in Jurkat cells after treatment with betulinic acid. Our results showed the proliferation of Jurkat cells was decreased in betulinic acid-treated group with a 24-h IC50 value being 70.00 μmol/L. Betulinic acid induced apoptosis of Jurkat cells in a time- and dose-dependent manner. The number of Jurkat cells treated with betulinic acid showed an increase in G₀/G₁ phase and decrease in S phase. After treatment with 0, 20, 60, 100 μmol/L betulinic acid for 24 h, the number of Jurkat cells was increased from (31.00±1.25)% to (58.84±0.32)% in G₀/G₁ phase, whereas it was decreased from (61.45±1.04)% to (35.82±1.95)% in S phase. PBMCs were less sensitive to the cytotoxicity of betulinic acid than Jurkat cells. The expressions of cyclin D3, bcl-xl mRNA and protein were decreased sharply in Jurkat cells treated with betulinic acid. It is concluded that betulinic acid is able to inhibit the proliferation of Jurkat cells by regulating the cell cycle, arrest cells at G₀/G₁ phase and induce the cell apoptosis. The anti-tumor effects of betulinic acid are related to the down-regulated expression of cyclin D3 and bcl-xl. Zi CHEN, Female, born in 1980, Resident This project was supported by a grant from the National Natural Sciences Foundation of China (No. 30500686).     

Curcumin down-regulates PCNA, cyclin D1 and Bcl-XL expression in human keratinocyte cell lines

Objective：To evaluate the effects of curcumin on regulating the proliferation,cell cycle distribution,apoptosis and relevant mechanisms in keratinocyte cell lines.Methods：The human immortalized human keratinocyte lines（HaCaT cells） were treated with different doses of curcumin.The effects of curcumin on cell viability were measured by MTT assay,and the cell cycle distribution and apoptosis determined by flow cytometry.The mRNA expression changes of proliferating cell nuclear antigen（PCNA）,cyclin D1 and Bcl-xL were from real-time PCR analysis and the protein levels were detected by Western blotting.Results：Data obtained in the study showed that curcumin could cause significantly inhibitory effect on proliferation in HaCaT cells in a time- and dose-dependent manner.Cell arrest at G1/S phase and significant apoptosis were observed after being treated with curcumin for 24 h.In association with these,the expression of PCNA,cyclin D1 and Bcl-xL were decreased both at mRNA and protein levels for the same treatment.Conclusion：Curcumin can inhibit proliferation,induce cell arrest at G1/S phase and cause apoptosis in HaCaT cells.The decreased expression of PCNA,cyclin D1 and Bcl-xL induced by curcumin contributes to the above effects in vitro.     

Growth inhibition and apoptosis inducing mechanisms of curcumin on human ovarian cancer cell line A2780

Curcumin,aphenolicpigmentextractedfrom curcuma,isthemajoreffectivecomponentofthat traditionalChinesemedicineandusedasadietarycoloringagentandanaturalcondiment.Recentre searchreportshaveshownthatcurcumincouldse lectivelyinhibittheproliferationandinducetheap optosisofmanytumorcells,buttheinvolvedmech anismsstillunclear(1,2).Thephenomenonthatcurcu mininducesapoptosisoftumorcellscouldbeseen innumerouscancers,however,theeffectsofcurcu minonhumanovariancancercellshavenotbeenre portedyet.Inthisresear…